ESC: Evidence Mounts for Injection to Lower LDL-C (CME/CE)

BARCELONA (MedPage Today) -- Four studies testing the injectable novel lipid-lowering agent alirocumab found the drug dramatically reduced LDL-cholesterol (LDL-C) among high-risk patients who had not achieved LDL targets using maximum tolerated statin therapy and/or ezetimibe.
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news